Related Experiment Video
Updated: Jun 1, 2026

06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Stereologic estimation of nuclear volume in glottic squamous-cell carcinoma
X Xie1, T Stenersen, O Clausen
1UNIV OSLO,NATL HOSP,DEPT OTOLARYNGOL,N-0027 OSLO,NORWAY. UNIV OSLO,NATL HOSP,DEPT PATHOL,N-0027 OSLO,NORWAY.
Oncology Reports
|May 21, 2011
Summary
Mean nuclear volume is a significant independent prognostic marker in glottic carcinomas. Higher nuclear volume (V) over bar v indicates a poorer prognosis, aiding in distinguishing between favorable and unfavorable cases.
Area of Science:
- Oncology
- Pathology
- Stereology
Background:
- Glottic carcinoma is a significant cause of cancer mortality.
- Accurate prognostic markers are crucial for effective treatment planning.
Purpose of the Study:
- To evaluate the prognostic value of mean nuclear volume (nuclear (V) over bar v) in glottic carcinomas.
- To determine if nuclear (V) over bar v can serve as an independent prognostic marker.
Main Methods:
- A stereologic model, the point sample intercept technique, was used to estimate nuclear (V) over bar v.
- Analysis was performed on 106 formalin-fixed, H&E-stained glottic carcinoma sections.
- Univariate and multivariate analyses were conducted to assess prognostic significance.
Main Results:
- The overall average nuclear (V) over bar v was 782 μm³.
- Patients with glottic carcinoma who died had a significantly higher nuclear (V) over bar v (917 μm³) compared to survivors (713 μm³).
- A cut-off level of 900 μm³ effectively separated favorable and poor prognostic cases (p=0.0004).
- Multivariate analysis identified N-stage and nuclear (V) over bar v as independent prognostic factors for survival.
Conclusions:
- Mean nuclear volume (nuclear (V) over bar v) is a strong independent prognostic marker in glottic carcinomas.
- Increased nuclear (V) over bar v is associated with a poorer prognosis.
- Nuclear (V) over bar v can aid in risk stratification and treatment decisions for glottic cancer patients.
